Histamine h3 receptor antagonist e177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats

Alaa Alachkar, Nadia Khan, Dorota Łażewska, Katarzyna Kieć-Kononowicz, Bassem Sadek

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Background: Alzheimer disease (AD) is the main cause of dementia in elderly people. The potential of histamine H3 receptor (H3R) antagonists as a pharmacological treatment of several neuropsychiatric diseases is well established. Methods: The novel non-imidazole-based H3R antagonist E177 was screened for its procognitive effects on the inhibitory avoidance paradigm (IAP) and novel object recognition (NOR) task in a dizocilpine (DIZ)-induced model of amnesia in male Wistar rats. Donepezil, an acetylcholine esterase inhibitor, was used as the reference drug. Results: Acute systemic treatment with E177 (1.25, 2.5, 5, and 10 mg/kg intraperitoneally [i.p.]) significantly attenuated the cognitive impairments induced by DIZ in the IAP (all P-values,0.05, n=7), and the protective effect of the most promising dose of E177 (5 mg/kg) was abrogated when H3R agonist R-(α)-methylhistamine (RAMH; 10 mg/kg i.p.) was co-administered (P=0.281 for DIZ-amnesia group vs DIZ + E177 + RAMH group, n=7). The discrimination index calculated for E177 (5 mg/kg, i.p.) showed a significant memory-enhancing effect on DIZ-induced shortterm memory impairment in the NOR task (P,0.05, n=6), with the enhancement nullified when animals were co-administered RAMH (10 mg/kg). Moreover, the results revealed that E177 (5 and 10 mg/kg, i.p.) did not alter the anxiety levels and locomotor activity of animals naïve to the open-field test (all P-values .0.05, n=8) or the elevated plus maze test (all P-values .0.05, n=6-8), which indicated that the E177-induced enhancement of memory performance in the IAP or NOR task was unrelated to changes in emotional response or in spontaneous locomotor activity. Conclusion: The observed results suggested a possible contribution of H3Rs in the alteration of brain neurotransmitters that accompany neurodegenerative diseases, such as AD.

Original languageEnglish
Pages (from-to)531-542
Number of pages12
JournalNeuropsychiatric Disease and Treatment
Publication statusPublished - 2019


  • Antagonist
  • Anxiety
  • Dizocilpine-induced amnesia
  • Elevated plus maze
  • Histamine h3 receptors
  • Inhibitory avoidance paradigm
  • Memory
  • Novel object recognition
  • Open field test

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Histamine h3 receptor antagonist e177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats'. Together they form a unique fingerprint.

Cite this